HomeMRKR • NASDAQ
add
Marker Therapeutics Inc
Previous close
$1.22
Day range
$1.19 - $1.26
Year range
$0.81 - $5.95
Market cap
20.67M USD
Avg Volume
227.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.23M | -35.99% |
Operating expense | 3.37M | -22.05% |
Net income | -2.00M | 13.41% |
Net profit margin | -162.11 | -35.27% |
Earnings per share | -0.12 | 53.85% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.59M | 95.45% |
Total assets | 21.73M | 99.21% |
Total liabilities | 3.35M | -3.32% |
Total equity | 18.39M | — |
Shares outstanding | 16.67M | — |
Price to book | 1.11 | — |
Return on assets | -29.27% | — |
Return on capital | -36.99% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -2.00M | 13.41% |
Cash from operations | -2.74M | -328.47% |
Cash from investing | — | — |
Cash from financing | 9.86M | 579,787.30% |
Net change in cash | 7.13M | 494.40% |
Free cash flow | -2.07M | -203.36% |
About
Founded
1992
Headquarters
Website
Employees
5
